{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T12:22:48Z","timestamp":1767874968278,"version":"3.49.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T00:00:00Z","timestamp":1764806400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T00:00:00Z","timestamp":1767744000000},"content-version":"vor","delay-in-days":34,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100005627","name":"Thrasher Research Fund","doi-asserted-by":"publisher","award":["15809"],"award-info":[{"award-number":["15809"]}],"id":[{"id":"10.13039\/100005627","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Radical cure with an 8-aminoquinoline is required to prevent relapses from\n                      <jats:italic>Plasmodium vivax<\/jats:italic>\n                      . Single-dose treatment with tafenoquine offers significant advantages over primaquine, but the amount of tafenoquine excreted in breastmilk is unknown. As tafenoquine can cause serious haemolysis in G6PD deficient individuals, the amount of drug in breastmilk must be determined in order to advise on safe and effective treatment for lactating women.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Six healthy lactating volunteers\u2009\u2265\u20091\u00a0year postpartum were recruited for this mother-only pilot pharmacokinetic study. Paired breastmilk and venous samples were taken on day 0, 1, 7 and 14. Breastmilk samples were collected in serial 5\u00a0ml aliquots to test foremilk and hindmilk drug concentrations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Tafenoquine concentrations in milk were similar to concentrations in blood (milk\/plasma ratio 1.09, range: 0.58\u20131.63). Concentrations were higher in hindmilk and in lower volume samples. Estimated drug passed to infants was calculated using a standard estimate of milk intake (150\u00a0ml per kg per day) and a high intake scenario (200\u00a0ml per kg per day). The maximum estimated dose that would be passed to the infant on a single day was 0.050\u00a0mg\/kg in the first 24\u00a0h (range 0.032\u20130.062\u00a0mg\/kg). Median weight-adjusted proportion of a therapeutic dose that infants would ingest (relative infant dose, RID) in total ranged from 5.07% (assuming of 150\u00a0ml milk per kg per day and 10\u00a0mg\/kg therapeutic dose) to 13.52% (assuming 200\u00a0ml milk per kg per day and 5\u00a0mg\/kg therapeutic dose). The drug was well tolerated by mothers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>This pilot study demonstrated measurable tafenoquine in breastmilk, with very small amounts of drug passing to babies on any given day but overall estimated RIDs around the conventional 10% threshold for safety concerns. Further studies are needed to determine with greater certainty the excretion of tafenoquine in breastmilk and drug concentrations in infant blood to inform recommendations for breastfeeding women.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12936-025-05685-z","type":"journal-article","created":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T16:32:55Z","timestamp":1764865975000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Tafenoquine lactation pharmacokinetics: a pilot study"],"prefix":"10.1186","volume":"25","author":[{"given":"Mary Ellen","family":"Gilder","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thanaporn","family":"Wattanakul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joel","family":"Tarning","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Warunee","family":"Hanpithakpong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laaongsri","family":"Niwetphongprai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cindy S.","family":"Chu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gornpan","family":"Gornsawun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wirawatn","family":"Tawantochai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eh","family":"Heet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Podjanee","family":"Jittamala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Saito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas J.","family":"White","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7ois","family":"Nosten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Germana","family":"Bancone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rose","family":"McGready","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,4]]},"reference":[{"key":"5685_CR1","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1056\/NEJMe1816383","volume":"380","author":"NJ White","year":"2019","unstructured":"White NJ. Tafenoquine \u2014 a radical improvement? N Engl J Med. 2019;380:285\u20136.","journal-title":"N Engl J Med"},{"issue":"3","key":"5685_CR2","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1080\/14740338.2021.1859476","volume":"20","author":"CS Chu","year":"2021","unstructured":"Chu CS, Hwang J. Tafenoquine: a toxicity overview. Expert Opin Drug Saf. 2021;20(3):349\u201362. https:\/\/doi.org\/10.1080\/14740338.2021.1859476.","journal-title":"Expert Opin Drug Saf"},{"issue":"4","key":"5685_CR3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0006440","volume":"12","author":"J Watson","year":"2018","unstructured":"Watson J, Taylor WRJ, Bancone G, Chu CS, Jittamala P, White NJ. Implications of current therapeutic restrictions for primaquine and tafenoquine in the radical cure of vivax malaria. PLoS Negl Trop Dis. 2018;12(4):e0006440. https:\/\/doi.org\/10.1371\/journal.pntd.0006440.","journal-title":"PLoS Negl Trop Dis"},{"key":"5685_CR4","doi-asserted-by":"crossref","unstructured":"Gilder ME, Hanpithakphong W, Hoglund RM, Tarning J, Win HH, Hilda N, et al. Primaquine pharmacokinetics in lactating women and breastfed infant exposures. Clin Infect Dis. 2018. 1000\u20137","DOI":"10.1093\/cid\/ciy235"},{"key":"5685_CR5","unstructured":"WHO. Guidelines for malaria, 30 November 2024. Geneva, World Health Organization. 2024. https:\/\/iris.who.int\/handle\/10665\/379635. Accessed 19 Feb 2025"},{"issue":"11","key":"5685_CR6","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00711-18","volume":"62","author":"N Thakkar","year":"2018","unstructured":"Thakkar N, Green JA, Koh GCKW, Duparc S, Tenero D, Goyal N. Population pharmacokinetics of tafenoquine, a novel antimalarial. Antimicrob Agents Chemother. 2018;62(11):e00711-18. https:\/\/doi.org\/10.1128\/AAC.00711-18.","journal-title":"Antimicrob Agents Chemother"},{"key":"5685_CR7","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1111\/bcp.12160","volume":"76","author":"AK Miller","year":"2013","unstructured":"Miller AK, Harrell E, Ye L, Baptiste-Brown S, Kleim JP, Ohrt C, et al. Pharmacokinetic interactions and safety evaluations of coadministered tafenoquine and chloroquine in healthy subjects. Br J Clin Pharmacol. 2013;76:858\u201367.","journal-title":"Br J Clin Pharmacol"},{"key":"5685_CR8","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/S2352-4642(21)00328-X","volume":"6","author":"ID V\u00e9lez","year":"2022","unstructured":"V\u00e9lez ID, Hien TT, Green JA, Martin A, Sharma H, Rousell VM, et al. Tafenoquine exposure assessment, safety, and relapse prevention efficacy in children with Plasmodium vivax malaria: open-label, single-arm, non-comparative, multicentre, pharmacokinetic bridging, phase 2 trial. Lancet Child Adolesc Health. 2022;6:86\u201395.","journal-title":"Lancet Child Adolesc Health"},{"key":"5685_CR9","unstructured":"GSK. Krintafel Product label. GlaxoSmithKline. 2018. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2018\/210795s000lbl.pdf"},{"key":"5685_CR10","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1002\/psp4.13311","volume":"14","author":"LM Almond","year":"2025","unstructured":"Almond LM, Abduljalil K, Pansari A, Kusmider B, Jones HM, Rowland Yeo K, et al. PBPK-led assessment of antimalarial drug concentrations in breastmilk: a strategy for optimal use of prediction methods to guide decision making in an understudied population. CPT Pharmacomet Syst Pharmacol. 2025;14:738\u201350.","journal-title":"CPT Pharmacomet Syst Pharmacol"},{"key":"5685_CR11","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1746-4358-4-7","volume":"4","author":"K Mizuno","year":"2009","unstructured":"Mizuno K, Nishida Y, Taki M, Murase M, Mukai Y, Itabashi K, et al. Is increased fat content of hindmilk due to the size or the number of milk fat globules? Int Breastfeed J. 2009;4:7.","journal-title":"Int Breastfeed J"},{"key":"5685_CR12","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.3390\/nu10081124","volume":"10","author":"S Verd","year":"2018","unstructured":"Verd S, Ginovart G, Calvo J, Ponce-Taylor J, Gaya A. Variation in the protein composition of human milk during extended lactation: a narrative review. Nutrients. 2018;10:1124.","journal-title":"Nutrients"},{"issue":"1","key":"5685_CR13","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1002\/cpt.377","volume":"100","author":"P Anderson","year":"2016","unstructured":"Anderson P, Sauberan J. Modeling drug passage into human milk. Clin Pharmacol Ther. 2016;100(1):42\u201352. https:\/\/doi.org\/10.1002\/cpt.377.","journal-title":"Clin Pharmacol Ther"},{"key":"5685_CR14","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1177\/0009922815594586","volume":"55","author":"PO Anderson","year":"2016","unstructured":"Anderson PO, Manoguerra AS, Vald\u00e9s V. A review of adverse reactions in infants from medications in breastmilk. Clin Pediatr (Phila). 2016;55:236\u201344.","journal-title":"Clin Pediatr (Phila)"},{"issue":"3","key":"5685_CR15","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1089\/bfm.2014.0170","volume":"10","author":"PO Anderson","year":"2015","unstructured":"Anderson PO, Vald\u00e9s V. Variation of milk intake over time: clinical and pharmacokinetic implications. Breastfeed Med. 2015;10(3):142\u20134. https:\/\/doi.org\/10.1089\/bfm.2014.0170.","journal-title":"Breastfeed Med"},{"issue":"5","key":"5685_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0196716","volume":"13","author":"G Bancone","year":"2018","unstructured":"Bancone G, Gornsawun G, Chu CS, Porn P, Pal S, Bansil P, et al. Validation of the quantitative point-of-care CareStart biosensor for assessment of G6PD activity in venous blood. PLoS ONE. 2018;13(5):e0196716. https:\/\/doi.org\/10.1371\/journal.pone.0196716.","journal-title":"PLoS ONE"},{"key":"5685_CR17","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1186\/s12888-020-02572-6","volume":"20","author":"G Fellmeth","year":"2020","unstructured":"Fellmeth G, Plugge E, Fazel M, Oo MM, Pimanpanarak M, Phichitpadungtham Y, et al. Prevalence and determinants of perinatal depression among labour migrant and refugee women on the Thai-Myanmar border: a cohort study. BMC Psychiatry. 2020;20:168.","journal-title":"BMC Psychiatry"},{"key":"5685_CR18","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1186\/s12888-018-1815-7","volume":"18","author":"G Fellmeth","year":"2018","unstructured":"Fellmeth G, Plugge EH, Nosten S, Oo MM, Fazel M, Charunwatthana P, et al. Living with severe perinatal depression: a qualitative study of the experiences of labour migrant and refugee women on the Thai-Myanmar border. BMC Psychiatry. 2018;18:229.","journal-title":"BMC Psychiatry"},{"key":"5685_CR19","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s13006-023-00599-5","volume":"18","author":"W Bowornkitiwong","year":"2023","unstructured":"Bowornkitiwong W, Komoltri C, Ngerncham S. The relationship between creamatocrit and cumulative percentage of total milk volume: a cross-sectional study in mothers of very preterm infants in Bangkok Thailand. Int Breastfeed J. 2023;18:63.","journal-title":"Int Breastfeed J"},{"key":"5685_CR20","doi-asserted-by":"publisher","first-page":"9822","DOI":"10.1038\/s41598-017-10045-2","volume":"7","author":"G Bancone","year":"2017","unstructured":"Bancone G, Kalnoky M, Chu CS, Chowwiwat N, Kahn M, Malleret B, et al. The G6PD flow-cytometric assay is a reliable tool for diagnosis of G6PD deficiency in women and anaemic subjects. Sci Rep. 2017;7:9822.","journal-title":"Sci Rep"},{"issue":"3","key":"5685_CR21","doi-asserted-by":"publisher","first-page":"702","DOI":"10.4269\/ajtmh.16-0779","volume":"97","author":"R Rueangweerayut","year":"2017","unstructured":"Rueangweerayut R, Bancone G, Harrell EJ, Beelen AP, Kongpatanakul S, M\u00f6hrle JJ, et al. Hemolytic potential of tafenoquine in female volunteers heterozygous for glucose-6-phosphate dehydrogenase (G6PD) deficiency (G6PD Mahidol Variant) versus G6PD-normal volunteers. Am J Trop Med Hyg. 2017;97(3):702\u201311. https:\/\/doi.org\/10.4269\/ajtmh.16-0779.","journal-title":"Am J Trop Med Hyg"},{"key":"5685_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.638885","volume":"12","author":"G Bancone","year":"2021","unstructured":"Bancone G, Chu CS. G6PD variants and haemolytic sensitivity to primaquine and other drugs. Front Pharmacol. 2021;12:638885.","journal-title":"Front Pharmacol"},{"key":"5685_CR23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0151898","volume":"11","author":"G Bancone","year":"2016","unstructured":"Bancone G, Chowwiwat N, Somsakchaicharoen R, Poodpanya L, Moo PK, Gornsawun G, et al. Single low dose primaquine (0.25mg\/kg) does not cause clinically significant haemolysis in G6PD deficient subjects. PLoS ONE. 2016;11:e0151898.","journal-title":"PLoS ONE"},{"key":"5685_CR24","doi-asserted-by":"publisher","first-page":"615","DOI":"10.2471\/BLT.23.291224","volume":"102","author":"L Luzzatto","year":"2024","unstructured":"Luzzatto L, Bancone G, Dugu\u00e9 PA, Jiang W, Minucci A, Nannelli C, et al. New WHO classification of genetic variants causing G6PD deficiency. Bull World Health Organ. 2024;102:615\u20137.","journal-title":"Bull World Health Organ"},{"issue":"1","key":"5685_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-019-2745-7","volume":"18","author":"A Setyadi","year":"2019","unstructured":"Setyadi A, Arguni E, Kenangalem E, Hasanuddin A, Lampah DA, Thriemer K, et al. Safety of primaquine in infants with Plasmodium vivax malaria in Papua, Indonesia. Malar J. 2019;18(1):111. https:\/\/doi.org\/10.1186\/s12936-019-2745-7.","journal-title":"Malar J"},{"key":"5685_CR26","unstructured":"US Federal Drug Administration. Clinical lactation studies: considerations for study design guidance for industry. Centre for Drug Evaluation and Research; FDA, Rockville, USA. 2019."},{"issue":"6","key":"5685_CR27","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1093\/jn\/nxaa059","volume":"150","author":"GE Leghi","year":"2020","unstructured":"Leghi GE, Middleton PF, Netting MJ, Wlodek ME, Geddes DT, Muhlhausler BS. A systematic review of collection and analysis of human milk for macronutrient composition. J Nutr. 2020;150(6):1652\u201370. https:\/\/doi.org\/10.1093\/jn\/nxaa059.","journal-title":"J Nutr"},{"key":"5685_CR28","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1177\/089033402237904","volume":"18","author":"EJ Begg","year":"2002","unstructured":"Begg EJ, Duffull SB, Hackett LP, Ilett KF. Studying drugs in human milk: time to unify the approach. J Hum Lact. 2002;18:323\u201332.","journal-title":"J Hum Lact"},{"issue":"8","key":"5685_CR29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0012351","volume":"18","author":"ND Wood","year":"2024","unstructured":"Wood ND, Smith D, Kinrade SA, Sullivan MT, Rayner CR, Wesche D, et al. The use of quantitative clinical pharmacology approaches to support moxidectin dosing recommendations in lactation. PLoS Negl Trop Dis. 2024;18(8):e0012351. https:\/\/doi.org\/10.1371\/journal.pntd.0012351.","journal-title":"PLoS Negl Trop Dis"},{"issue":"5","key":"5685_CR30","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1111\/j.1365-2125.2008.03111.x","volume":"65","author":"I Law","year":"2008","unstructured":"Law I, Ilett KF, Hackett LP, Page-Sharp M, Baiwog F, Gomorrai S, et al. Transfer of chloroquine and desethylchloroquine across the placenta and into milk in Melanesian mothers. Br J Clin Pharmacol. 2008;65(5):674\u20139. https:\/\/doi.org\/10.1111\/j.1365-2125.2008.03111.x.","journal-title":"Br J Clin Pharmacol"},{"key":"5685_CR31","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s12936-018-2248-y","volume":"17","author":"CS Chu","year":"2018","unstructured":"Chu CS, Bancone G, Nosten F, White NJ, Luzzatto L. Primaquine-induced haemolysis in females heterozygous for G6PD deficiency. Malar J. 2018;17:101.","journal-title":"Malar J"},{"key":"5685_CR32","doi-asserted-by":"publisher","first-page":"1258905","DOI":"10.3389\/fnut.2024.1258905","volume":"11","author":"KT Kivlighan","year":"2024","unstructured":"Kivlighan KT, Schneider SS, Browne EP, Pentecost BT, Anderton DL, Arcaro KF. Mammary epithelium permeability during established lactation: associations with cytokine levels in human milk. Front Nutr. 2024;11:1258905.","journal-title":"Front Nutr"}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-025-05685-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12936-025-05685-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-025-05685-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T03:03:24Z","timestamp":1767841404000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12936-025-05685-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,4]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5685"],"URL":"https:\/\/doi.org\/10.1186\/s12936-025-05685-z","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,4]]},"assertion":[{"value":"6 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol and its associated documents were approved by the Oxford Tropical Research Ethics Committee (OXTREC 20\u201321) and the Faculty of Tropical Medicine Ethics Committee (TMEC 21\u2013083), Mahidol University. In addition, the Tak Province Border Community Ethics Advisory Board (T-CAB) was consulted for local feedback and advice.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval consent to participate"}},{"value":"Joel Tarning is a paid consultant on the Novartis Malaria Advisory Board, and payments are made directly to the host organization and used for research purposes. No direct personal payments have been carried out. All other authors declare no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"15"}}